As of 2025-10-14, the Relative Valuation of Bioventus Inc (BVS) is (0.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.57 USD, the upside of Bioventus Inc based on Relative Valuation is -100.5%.
The range of the Relative Valuation is (0.02) - (0.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 25.3x | 15.5x |
| Forward P/E multiples | 12.8x - 20.7x | 16.0x |
| Fair Price | (0.02) - (0.04) | (0.03) |
| Upside | -100.4% - -100.6% | -100.5% |
| Date | P/E |
| 2025-10-13 | -3,438.02 |
| 2025-10-10 | -3,406.63 |
| 2025-10-09 | -3,448.49 |
| 2025-10-08 | -3,537.45 |
| 2025-10-07 | -3,479.89 |
| 2025-10-06 | -3,553.15 |
| 2025-10-03 | -3,673.50 |
| 2025-10-02 | -3,511.28 |
| 2025-10-01 | -3,511.28 |
| 2025-09-30 | -3,500.82 |
| 2025-09-29 | -3,464.19 |
| 2025-09-26 | -3,485.12 |
| 2025-09-25 | -3,537.45 |
| 2025-09-24 | -3,605.48 |
| 2025-09-23 | -3,621.17 |
| 2025-09-22 | -3,631.64 |
| 2025-09-19 | -3,626.41 |
| 2025-09-18 | -3,767.70 |
| 2025-09-17 | -3,626.41 |
| 2025-09-16 | -3,579.31 |
| 2025-09-15 | -3,752.00 |
| 2025-09-12 | -3,783.39 |
| 2025-09-11 | -3,809.56 |
| 2025-09-10 | -3,663.04 |
| 2025-09-09 | -3,804.33 |
| 2025-09-08 | -3,772.93 |
| 2025-09-05 | -3,762.46 |
| 2025-09-04 | -3,715.37 |
| 2025-09-03 | -3,683.97 |
| 2025-09-02 | -3,778.16 |
| 2025-08-29 | -3,872.35 |
| 2025-08-28 | -3,793.86 |
| 2025-08-27 | -3,919.45 |
| 2025-08-26 | -3,804.33 |
| 2025-08-25 | -3,893.29 |
| 2025-08-22 | -3,997.94 |
| 2025-08-21 | -3,704.90 |
| 2025-08-20 | -3,772.93 |
| 2025-08-19 | -3,830.49 |
| 2025-08-18 | -3,757.23 |
| 2025-08-15 | -3,856.66 |
| 2025-08-14 | -3,840.96 |
| 2025-08-13 | -3,940.38 |
| 2025-08-12 | -3,825.26 |
| 2025-08-11 | -3,626.41 |
| 2025-08-08 | -3,621.17 |
| 2025-08-07 | -3,626.41 |
| 2025-08-06 | -3,814.79 |
| 2025-08-05 | -3,213.01 |
| 2025-08-04 | -3,307.20 |